B. Jullienne

Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver.

P. Opolon, E. Connault, M. Perricaudet, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Respective roles of TNF-α and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice

P. Opolon, E. Connault, M. Perricaudet, 2007, Gene Therapy.

Respective roles of TNF-α and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice

P. Opolon, E. Connault, M. Perricaudet, 2007, Gene Therapy.

Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid

M. Perricaudet, R. Chaligné, F. Vigant, 2009, Gene Therapy.

Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.

P. Opolon, E. Connault, M. Perricaudet, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.

J. Marks, B. Jullienne, K. Benihoud, 2010, Cancer research.

Integrin αvβ3 and disulfide bonds play important roles in NGR-retargeted adenovirus transduction efficiency.

D. Majhen, B. Jullienne, K. Benihoud, 2021, Life sciences.